Radient Technologies Inc. Announces Addition of Three Key Members to its Management Team
EDMONTON, Alberta, March 25, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that it has appointed Mr. Adrian Marshall and Mr. James Blakelock to the joint role of Executive Vice President, Corporate Strategy and Planning, and Mr. Bill Wasson to the role of Senior Vice President, Capital Markets and Investor Relations. Working closely with Radient’s existing Management Team and Board of Directors, they will be instrumental in developing, driving and communicating the Company’s corporate strategy and global expansion.
Denis Taschuk, CEO & President of Radient, commented: “These additions to our management team are very strategic in nature, and we consider ourselves fortunate to have attracted such top talent as we move forward with our global expansion plans. Both Mr. Marshall and Mr. Blakelock bring to Radient decades of experience working directly with some of the world’s leading rapid growth consumer products companies, while Mr. Wasson brings his extensive experience in investment banking and corporate advisory, having also been an early mover in corporate financing within the cannabis sector.”
Adrian Marshall, Executive Vice President of Corporate Strategy and Planning
Mr. Marshall is an experienced senior executive and entrepreneur with a wealth of expertise in corporate strategy, international sales & marketing, corporate affairs, and communications. He spent his early career in the beverages, soft paper and tobacco sectors creating & launching new consumer goods brands across markets in the UK, Japan, Russia, the Middle East, and Africa.
Mr. Marshall was the first global head of Corporate Social Responsibility to be appointed by a major tobacco group, British American Tobacco (“BAT”). As Director of BAT’s global ‘harm-reduction’ programme, he was the architect of the group’s strategy to research, develop, assess and commercialize new alternative products such as smokeless tobacco, electronic cigarettes and nicotine inhalers.
After leading BAT’s global harm-reduction efforts for 5 years, Mr. Marshall launched Nicoventures Ltd, a new UK healthcare start-up within the BAT group. Under his leadership, Nicoventures was the first, and to date the only, company to succeed in obtaining a Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for a novel nicotine inhalation product with general sale list classification and the harm reduction label, “a safer alternative to smoking.”
Mr. Marshall has started several companies of his own in the technology, marketing, communications and consultancy fields. He holds a BSc. (Hons) in Philosophy from the University of Hull and is an experienced executive leadership coach.
James Blakelock, Executive Vice President of Corporate Strategy and Planning
Prior to joining Radient, Mr. Blakelock worked for 26 years with BAT where he acquired significant international sales, marketing, and country management experience in the United Arab Emirates, Saudi Arabia, Singapore, Cambodia, and Russia.
Mr. Blakelock held numerous senior executive roles within the BAT Group including Global Head of Regulation, Global Head of Sustainability, Regional Corporate and Regulatory Affairs Director for Eastern Europe, the Middle East, and Africa, and served as a Director of BAT Malaysia Plc.
Mr. Blakelock was responsible for leading BAT’s global regulatory engagement activities, BAT’s successful listing as the only tobacco company in the Dow Jones Sustainability Index, leading the international roll-out of BAT’s award winning social and environmental reporting initiative, and the development of BAT’s global corporate business principles.
He holds a BA (Hons) in Business Studies, a diploma from the Chartered Institute of Marketing, and was recently awarded the Financial Times Non-Executive Director diploma.
William (Bill) Wasson, Senior Vice President, Capital Markets and Investor Relations
Mr. Wasson is a seasoned finance professional with over 25 years of experience providing corporate debt, equity, and advisory services to a wide variety of private and public entities.
Prior to joining Radient, he held senior management roles in corporate credit, investment banking, and private equity. Through his previous roles at TD Bank, National Bank, and multiple boutique dealers, Mr. Wasson has helped finance some of Canada’s largest corporate entities. Additionally, he has fostered groundbreaking financing initiatives in the renewable power, infrastructure, and cannabis sectors in Canada.
Mr. Wasson graduated from McMaster University with a Bachelor of Commerce, and he holds a Chartered Director designation from The Directors College at the DeGroote School of Business.
As Senior Vice President, Capital Markets and Investor Relations for Radient, and subject to approval from the TSX Venture Exchange, Mr. Wasson will be working alongside Radient’s Management Team and Board of Directors to communicate directly with investors, analysts, and shareholders regarding publicly disclosed information pertaining to the Company. He will also be advising the Company on various capital markets strategies, including analyzing potential mergers and acquisitions opportunities on behalf of Radient.
Shares for Services:
The Company intends to issue shares to a company controlled by Messrs. Marshall and Blakelock as compensation for their corporate strategy and planning services. Pursuant to the terms of the agreement, Radient may issue £48,750 of common shares a month in consideration for such services.
The number of shares to be issued for each month will be determined at the end of each month, after the services have been provided to the Company. The issue price of the shares will be the greater of (i) the 15 day VWAP of Radient shares on the last trading day of such month; and (ii) the “Discounted Market Price” (as defined in the TSX Venture Exchange policies) on the last trading day of such month. Further, if certain revenue milestones are reached by Radient as a result of the services provided by Messrs. Marshall and Blakelock, Radient shall issue additional shares as consideration for the services of Messrs. Marshall and Blakelock. The Company will issue a press release after each issuance of shares under the terms of the Agreement.
The agreement shall automatically renew for successive one-year terms, subject to the rights of termination of the parties. The shares for services agreement is subject to approval by the TSX Venture Exchange and will be subject to TSX Venture Exchange approval for each renewal term.
Proposed Shares for Debt Transaction:
Radient also announces a proposed shares-for-debt transaction in which Radient would issue up to 96,252 common shares, at a price of CAD $1.02 per share, to an arm's length third party creditor of the Company in connection with the settlement of an aggregate of USD $73,206 of debt. The shares for debt transaction is conditional on TSX Venture Exchange approval. All securities to be issued pursuant to this settlement will be subject to a 4-month hold period.
Radient Technologies provides industrial-scale manufacturing solutions for premium natural ingredients and products. Utilizing its patented MAP™ extraction technology, Radient delivers superior customer outcomes in terms of ingredient purity, yield, and cost, serving global market leaders in industries such as foods & beverages, nutraceuticals, pharmaceuticals, cosmetics, and personal care. Since 2016, Radient has expanded its offerings to enter the cannabinoids market, using its MAP™ platform to provide premium ingredients that contain a full range of cannabinoid and terpene profiles. Please visit www.radientinc.com for more information.
SOURCE: Radient Technologies Inc.
Denis Taschuk, Chief Executive Officer: firstname.lastname@example.org,
Prakash Hariharan, Chief Financial Officer: email@example.com,
For press and media enquiries, please contact Caitlin Cheadle, Director of Communications: firstname.lastname@example.org
For investment enquiries, please contact Bill Wasson, Senior VP of Capital Markets and Investor Relations: email@example.com
Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the impact of managerial appointments; the shares for services arrangements; the shares for debt proposal; Company’s ability to expand its operations in Europe and Canada; the Company’s ability to grow its business in the cannabis sector and the Company’s future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Real World Cloud Orchestration Facilitates Easy Migration to All-IP18.4.2019 22:05:00 CEST | Pressemelding
For All-IP service providers in Malta and the Netherlands, Patton Cloud edge orchestration has lowered costs with fast, simple activation and management of enterprise IP-Telephony services SmartNode VoIP… More than Just Talk! BERN, Switzerland, April 18, 2019 (GLOBE NEWSWIRE) -- Patton—a U.S. network-equipment manufacturer and multi-national provider of enabling solutions for virtualized network function virtualization (NFV) SD-WAN, All-IP, and unified communications (UC) services—has saved the day for Dutch and Maltese national IP-communications providers with its Patton Cloud network edge orchestration service. VIDEO: Cloud Powered Services Netherlands ISDN Services are going away in the Netherlands. Yet scores of business subscribers can't simply jump into an All-IP network overnight. Investments in ISDN-based systems, fused with established business-processes, preclude such reckless dismantling of on-premise legacy systems. Business customers need flexibility to manage migration to
Acreage Holdings Announces Signing of Arrangement Agreement18.4.2019 17:02:00 CEST | Pressemelding
FRANKFURT, Germany, April 18, 2019 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage”) (CSE:ACRG.U) (OTC:ACRGF) (FSE:0VZ) and Canopy Growth Corporation (“Canopy Growth”) (TSX:WEED) (NYSE:CGC) (together, the “Companies”) entered into a definitive arrangement agreement (the "Agreement") that grants Canopy Growth the right to acquire 100 percent of the shares of Acreage (the “Right”), with a requirement to do so at such time as cannabis production and sale becomes federally legal in the United States of America (the "Transaction"), subject to obtaining the requisite prior approval of the shareholders of each of Acreage and Canopy Growth, respectively (the “Shareholder Approval”), as well as the approval of the Supreme Court of British Columbia, Canada (the “Court Approval”). Following the Shareholder Approval and the Court Approval, under the terms of the Agreement, and upon exercise of the Right, the total consideration payable pursuant to the Transaction is valued at approximatel
WillScot to Participate at the Credit Suisse Extreme Services Conference18.4.2019 16:19:00 CEST | Pressemelding
BALTIMORE, April 18, 2019 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that Brad Soultz, President and Chief Executive Officer, and Tim Boswell, Chief Financial Officer, will host a day of one-on-one and group meetings with investors at the Credit Suisse Extreme Services Conference to be held at Credit Suisse’s New York City office, on Tuesday, May 7, 2019. About WillScot Corporation Headquartered in Baltimore, Maryland, WillScot is the public holding company for the Williams Scotsman family of companies. WillScot trades on the Nasdaq stock exchange under the ticker symbol "WSC," and is the specialty rental services market leader providing innovative modular space and portable storage solutions across North America. WillScot is the modular space supplier of choice for the construction, education, health care, governm
TrueCommerce Datalliance Releases First Platform Update of 201918.4.2019 16:00:00 CEST | Pressemelding
Supply chain software company expands self-service options, more control for customers’ data CINCINNATI, April 18, 2019 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity, integration and unified commerce solutions, has announced today that TrueCommerce Datalliance, its division focusing on vendor managed inventory (VMI) and collaborative replenishment (CR) software, has released its first of three software updates for 2019. In addition to general reliability and stability fixes, the update provides customers with more control over updating specific fields and who has access to that information, as well as adding store-driven demand. Doug Bethea, Vice President of Consumer Goods Solutions said, “Every update is multifaceted. We implement necessary security changes and adjust code to optimize performance for our customers. We also bring our own ideas as value-adds. Additionally, we are always working with customers to implement advanced features as it is
Constellation Brands Enters Into Agreement with Canopy Growth Corporation to Modify Warrants and Other Rights18.4.2019 15:33:00 CEST | Pressemelding
VICTOR, N.Y., April 18, 2019 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, today announced that it plans to enter into an agreement with Canopy Growth Corporation (“Canopy”) (TSX: WEED, NYSE: CGC), a leading diversified cannabis company, to modify certain warrants and other rights. These changes are the result of Canopy’s intentions to acquire Acreage Holdings, Inc. (“Acreage”) upon U.S. Federal cannabis legalization. Earlier today, Canopy announced (see Canopy press release “Canopy Growth Announces Option to Acquire Leading U.S. Multi-state Cannabis Operator, Acreage Holdings”) it has entered into an agreement with Acreage, a U.S. multi-state cannabis operator, where Canopy plans to acquire the shares of Acreage upon U.S. Federal cannabis legalization (the “Triggering Event”), subject to certain conditions. This transaction, as well as proposed modifications to certain Constellation warrants, are subject to approval by Canopy
Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events18.4.2019 14:00:00 CEST | Pressemelding
World’s First Phase 3 BET Bromodomain Epigenetics Trial Reaches Events Target CALGARY, Alberta, April 18, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that BETonMACE, the Company’s event-based, phase 3 registration trial has successfully reached 250 projected major adverse cardiac events (MACE), strictly defined as cardiovascular death, non-fatal myocardial infarction and stroke, moving the trial towards completion. Successful data from this trial would enable Resverlogix to proceed towards the regulatory approval and commercialization of its lead drug, apabetalone. “Resverlogix staff and stakeholders have worked diligently for the past 18 years to attain this extremely exciting goal,” said Donald McCaffrey, President and CEO of Resverlogix. “The trial’s extensive breakthrough clinical data will soon be available to Resverlogix. Successfully meeting the trial’s endpoints, the substantial data set and otherwise new findings would